| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |